Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

Science(2018)10.1126/science.aao4750Source: DataRank Database

Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq is a research paper published in Science (2018). On theSindex it has a DataRank of 0.989. It has been cited 728 times.

N/A

0.989DataRank · unranked

Scored on demand from live citation data

Open Access728 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (18 grants)Impact (FWCI 35.42)OA: greenTopics (27)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.989

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (51)

Itay Tirosh ORCID,Volker Hovestadt ORCID,Leah E. Escalante ORCID,Nathan D. Mathewson ORCID,Cyril Neftel ORCID

Live enrichment

PubMed:29674595 PMC:PMC5949869 OpenAlex:https://openalex.org/W2802053370

NIH Office of the Director

Grant: DP1CA216873

National Cancer Institute

Grant: P50CA165962

National Cancer Institute

Grant: NCI P01 CA142536

National Cancer Institute

Grant: 1U24CA180922

National Cancer Institute

Grant: R33CA202820

NCI NIH HHS

Grant: R01 CA215489

NCI NIH HHS

Grant: R01 CA219943

NCI NIH HHS

Grant: P01 CA142536

NCRR NIH HHS

Grant: S10 RR023440

NCI NIH HHS

Grant: P30 CA014051

NCI NIH HHS

Grant: R01 CA188228

NCI NIH HHS

Grant: K12 CA090354

NCI NIH HHS

Grant: U24 CA180922

alexslemonade

Richard and Susan Smith Family Foundation

Howard Hughes Medical Institute

The V Foundation

The Cure Starts Now

FWCI

35.42

Citation Percentile

1.0%

Citation Trend

2018

2019

2020

2021

2022

2023

2024

2025

2026

greenLicense: cc-by-nc

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/5949869

publisherhttps://syndication.highwire.org/content/doi/10.1126/science.aao4750

publisherhttps://www.science.org/doi/pdf/10.1126/science.aao4750

journalhttps://doi.org/10.1126/science.aao4750

Fields of Study

Glioma Diagnosis and TreatmentSingle-cell and spatial transcriptomicsExtracellular vesicles in disease

MeSH Terms

Brain NeoplasmsGliomaHistonesHumansMutationOligodendrogliaOncogenesSequence Analysis, RNAReceptor, Platelet-Derived Growth Factor alphaMitogen-Activated Protein Kinase 7Cell ProliferationSingle-Cell AnalysisCarcinogenesis

Keywords

RNA-SeqRNACellBiologyGliomaComputational biologyCell biologyGene expressionGeneticsTranscriptomeGene

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma

10.6084/m9.figshare.12057201.v1figshare

Additional file 1 of CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma

10.6084/m9.figshare.12057201figshare

Additional file 5 of CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma

10.6084/m9.figshare.12057216.v1figshare

Additional file 5 of CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma

10.6084/m9.figshare.12057216figshare

Additional file 1 of Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

10.6084/m9.figshare.19687414.v1figshare

Additional file 1 of Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

10.6084/m9.figshare.19687414figshare

Additional file 2 of Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

10.6084/m9.figshare.19687417.v1figshare

Additional file 2 of Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

10.6084/m9.figshare.19687417figshare

Additional file 1 of Histone H3.3 K27M chromatin functions implicate a network of neurodevelopmental factors including ASCL1 and NEUROD1 in DIPG

10.6084/m9.figshare.19801953.v1figshare

Additional file 1 of Histone H3.3 K27M chromatin functions implicate a network of neurodevelopmental factors including ASCL1 and NEUROD1 in DIPG

10.6084/m9.figshare.19801953figshare

Additional file 2 of Elucidating the diversity of malignant mesenchymal states in glioblastoma by integrative analysis

10.6084/m9.figshare.21162817.v1figshare

Additional file 2 of Elucidating the diversity of malignant mesenchymal states in glioblastoma by integrative analysis

10.6084/m9.figshare.21162817figshare

Additional file 4 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma

10.6084/m9.figshare.21385811.v1figshare

Additional file 4 of Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma

10.6084/m9.figshare.21385811figshare

Additional file 1 of Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin

10.6084/m9.figshare.22598839.v1figshare

Additional file 1 of Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin

10.6084/m9.figshare.22598839figshare

Additional file 1 of Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML

10.6084/m9.figshare.24070154.v1figshare

Additional file 1 of Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML

10.6084/m9.figshare.24070154figshare

Additional file 12 of Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML

10.6084/m9.figshare.24070199.v1figshare

Additional file 12 of Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML

10.6084/m9.figshare.24070199figshare